Literature DB >> 1909583

Long-term effects of elemental and exclusion diets for Crohn's disease.

M H Giaffer1, P Cann, C D Holdsworth.   

Abstract

Previous studies have confirmed the therapeutic value of elemental diets in promoting remission in active Crohn's disease, but their long-term benefit has not been established. Twenty-seven patients with established Crohn's disease who attained clinical remission after four weeks of enteral feeding were followed prospectively for up to 36 months. Twenty of these were willing to be tested for specific food intolerance using a pre-defined dietary elimination protocol; the others continued on a normal unrestricted diet. Eighteen patients (67%) have since relapsed; 89% of the relapse occurred within the first 6 months. Of the 15 patients with colonic involvement, 12 (80%) relapsed by 6 months. In contrast only 3 of 11 with isolated small bowel disease experienced early relapse. Of the 14 patients who completed the process of dietary testing, 5 could not identify any trigger foods; the remaining 9 were maintained on exclusion diets, 3 of whom relapsed early. Of the 11 taking a normal diet, 9 relapsed. Disease duration, previous intestinal resection or prior steroid therapy did not affect the relapse rate. Eight patients (31%) obtained a long-term remission, mean 23 months (range 12-36 months), without any medication. Long-lasting remissions can be obtained in about one-third of patients with Crohn's disease following treatment with a defined formula diet. Colonic involvement is associated with a high early relapse rate.

Entities:  

Mesh:

Year:  1991        PMID: 1909583     DOI: 10.1111/j.1365-2036.1991.tb00012.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

1.  Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.

Authors:  M H Giaffer; A Clark; C D Holdsworth
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 2.  Pharmacoeconomics of the therapy of diarrhoeal disease.

Authors:  K A Nathavitharana; I W Booth
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

3.  Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.

Authors:  D A Gorard; J B Hunt; J J Payne-James; K R Palmer; R G Rees; M L Clark; M J Farthing; J J Misiewicz; D B Silk
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

4.  Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease.

Authors:  J C Mansfield; M H Giaffer; C D Holdsworth
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

5.  Food intolerance and Crohn's disease.

Authors:  M Pearson; K Teahon; A J Levi; I Bjarnason
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

6.  Enteral nutrition for maintenance of remission in Crohn's disease.

Authors:  Anthony K Akobeng; Dongni Zhang; Morris Gordon; John K MacDonald
Journal:  Cochrane Database Syst Rev       Date:  2018-08-11

Review 7.  Dietary Strategies for Maintenance of Clinical Remission in Inflammatory Bowel Diseases: Are We There Yet?

Authors:  Konstantinos Gkikas; Konstantinos Gerasimidis; Simon Milling; Umer Z Ijaz; Richard Hansen; Richard K Russell
Journal:  Nutrients       Date:  2020-07-07       Impact factor: 5.717

Review 8.  Enteral Nutrition in Adult Crohn's Disease: Toward a Paradigm Shift.

Authors:  Simona Di Caro; Konstantinos C Fragkos; Katie Keetarut; Hui Fen Koo; Gregory Sebepos-Rogers; Hajeena Saravanapavan; John Barragry; Jennifer Rogers; Shameer J Mehta; Farooq Rahman
Journal:  Nutrients       Date:  2019-09-14       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.